Cadrenal Therapeutics, INC. (CVKD) — S-1 Filings
All S-1 filings from Cadrenal Therapeutics, INC.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
Cadrenal Files S-1 for Resale of 428K Shares, Acquires VLX-1005 Asset
— Dec 29, 2025 Risk: medium
Cadrenal Therapeutics, Inc. (CVKD) filed an S-1 on December 23, 2025, primarily for the resale of up to 428,227 shares of common stock by Selling Stockholders.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX